CAM

Cormorant Asset Management Portfolio holdings

AUM $1.76B
1-Year Est. Return 415.22%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+415.22%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.45B
AUM Growth
+$107M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
44
New
Increased
Reduced
Closed

Top Buys

1
+$156M
2
+$7.91M
3
+$7.02M
4
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$4.71M
5
RAPP
Rapport Therapeutics
RAPP
+$4.49M

Top Sells

1
+$339M
2
+$58.9M
3
+$33.1M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$30.3M
5
SPRY icon
ARS Pharmaceuticals
SPRY
+$19.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAM
26
Avidity Biosciences
RNAM
$11.2B
$13.1M 0.9%
300,000
+100,000
BIOA
27
BioAge Labs
BIOA
$930M
$12.6M 0.87%
2,140,605
AXSM icon
28
Axsome Therapeutics
AXSM
$8.38B
$12.1M 0.84%
100,000
CABA icon
29
Cabaletta Bio
CABA
$320M
$11.7M 0.81%
5,000,000
ORKA
30
Oruka Therapeutics
ORKA
$1.67B
$10.3M 0.71%
+533,340
ALMS
31
Alumis Inc
ALMS
$3.7B
$8.57M 0.59%
2,147,396
BMEA icon
32
Biomea Fusion
BMEA
$96.9M
$7.21M 0.5%
3,570,872
AMLX icon
33
Amylyx Pharmaceuticals
AMLX
$1.67B
$6.79M 0.47%
+500,000
PCVX icon
34
Vaxcyte
PCVX
$8.86B
$6.3M 0.43%
175,000
ELVN icon
35
Enliven Therapeutics
ELVN
$1.76B
$4.09M 0.28%
200,000
BHVN icon
36
Biohaven
BHVN
$1.53B
$150K 0.01%
10,000
KALA icon
37
KALA BIO
KALA
$346M
– –
-603,027
MRUS
38
DELISTED
Merus
MRUS
– –
-1,120,000
CRGX
39
DELISTED
CARGO Therapeutics
CRGX
– –
-3,381,277
SPRY icon
40
ARS Pharmaceuticals
SPRY
$917M
– –
-1,100,000
STOK icon
41
Stoke Therapeutics
STOK
$2.08B
– –
-254,161
VRNA
42
DELISTED
Verona Pharma
VRNA
– –
-350,000
VYNE icon
43
VYNE Therapeutics
VYNE
$20M
– –
-1,370,938
AARD
44
Aardvark Therapeutics
AARD
$272M
– –
-800,189
1
2